Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Transcriptomic and Proteomic Analysis of Tau-dependent E/I Imbalance

Award Number: R21AG085079
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/16/2023
PERIOD OF PERFORMANCE END DATE: 09/15/2025

Group Awards By:

View Award Description

Transcriptomic and Proteomic Analysis of Tau-dependent E/I Imbalance - SUMMARY Evidence for excitation/inhibition (E/I) imbalance of neural networks has been found in diverse brain disorders that are prevalent, devastating, and refractory or poorly responsive to available therapies, including Alzheimer’s disease (AD), epilepsy, and autism spectrum disorders. In animal models for these conditions, reducing overall levels of non-aggregated, endogenous, wildtype tau prevents or diminishes disease manifestations triggered by diverse causes, ranging from the neural accumulation of amyloid proteins to mutations in genes encoding sodium or potassium channels, stroke, and the pharmacological blockade of neurotransmitter receptors. Since all of these abnormalities promote E/I imbalance and network hyperexcitability, which can disrupt important processes required for the health of neurons and other brain cells, we hypothesize that the reduced E/I ratio in tau-deficient brains explains, at least in good part, the broad therapeutic benefits of overall tau reduction. Here, we propose to explore the underlying molecular mechanisms by combining cell type-specific tau ablation and chemically induced E/I imbalance with molecular profiling analyses focused on excitatory forebrain neurons. Previous studies have revealed that tau can bind to or interact with a plethora of other proteins. Because many, if not most, of these tau-interacting proteins have the potential to affect neuronal activities, the primary mechanisms by which tau enables and tau reduction counteracts network hyperexcitability remain to be determined. In light of our recent discovery that selective ablation of tau in excitatory, but not inhibitory, neurons is sufficient to counteract E/I imbalance, we hypothesize that these mechanisms can be revealed by comparing the molecular profile of excitatory neurons that do or do not express tau before and during the emergence of chemically induced network hyperexcitability. We propose to test this hypothesis at the mRNA level (Aim 1) and at the protein level (Aim 2). Because of complementary strengths and weaknesses of these approaches and our related experimental designs, we further hypothesize that an integrative analysis of the resulting datasets (Aim 3) has the best chance to pinpoint the most critical mechanisms by which tau enables and tau reduction counteracts the development of E/I imbalance under pathological conditions. Identifying these mechanisms could provide new insights into the pathobiology of tau, help guide the development and evaluation of tau-targeting therapeutics, and result in the identification of additional indications and drug targets.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2023	J.DAVID GLADSTONE INSTITUTES	1650 OWENS ST	SAN FRANCISCO	CA	94158	SAN FRANCISCO	USA	Aging Research	000	1	1/29/2026	NEW	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $519,750 )
2023	2023	J.DAVID GLADSTONE INSTITUTES	1650 OWENS ST	SAN FRANCISCO	CA	94158	SAN FRANCISCO	USA	Aging Research	000	1	9/15/2023	NEW	$519,750
2023	2023	J.DAVID GLADSTONE INSTITUTES	1650 OWENS ST	SAN FRANCISCO	CA	94158	SAN FRANCISCO	USA	Aging Research	001	1	9/19/2023	NEW	$0
														Subtotal = $519,750

Grand Total All Awards = $519,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Transcriptomic and Proteomic Analysis of Tau-dependent E/I Imbalance

Award Number: R21AG085079

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/16/2023

PERIOD OF PERFORMANCE END DATE: 09/15/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer